Latest UTMD reports update at 2024-03-26: 202320222021
Utah Medical Products logo
Utah Medical Products UTMD
$ 69.45 0.67%

Utah Medical Products Financial Ratios 2011-2024 | UTMD

Annual Financial Ratios Utah Medical Products

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

57.7 74.2 79.5 89.6 25.5 18.8 40.2 19.1 18.0 18.8 17.7 14.9 14.7

P/S

20.1 24.9 25.4 25.5 8.0 8.3 8.3 5.9 5.3 5.2 5.0 3.6 2.9

EPS

4.6 4.5 4.0 3.0 4.0 5.0 2.3 3.2 3.2 3.0 3.1 2.8 2.0

EV (Enterprise Value)

162 M 272 M 276 M 263 M 342 M 308 M 316 M 213 M 199 M 211 M 207 M 168 M 138 M

EBITDA per Share

4.79 5.61 5.35 3.93 6.56 5.82 5.86 5.05 4.98 5.18 4.78 4.97 4.02

EV/EBITDA

14.1 12.7 13.6 13.7 13.9 10.8 10.1 10.2 10.9 8.4 8.5

PEG

-278.23 28.68 16.49 -41.82 -1.21 0.16 -1.39 7.51 4.33 -81.17 1.72 0.43 0.65

P/B

1.9 3.0 3.1 3.0 3.7 3.9 4.4 3.4 3.1 3.3 3.3 3.0 2.7

P/CF

11.1 16.0 15.5 15.2 -83.8 21.2 22.3 20.7 15.7 15.0 16.8 11.4 9.8

ROE %

3.34 3.99 3.86 3.32 14.57 20.85 10.89 17.51 17.00 17.63 18.83 19.95 18.19

ROA %

3.16 3.68 3.57 3.05 13.41 18.60 9.17 15.84 14.96 14.03 14.13 13.22 9.71

ROCE %

13.08 17.32 17.62 13.33 16.58 19.78 21.74 22.00 20.84 22.47 20.28 21.99 17.74

Current Ratio

19.0 12.9 13.6 12.5 15.9 11.6 9.3 11.5 8.1 3.3 3.2 2.4 1.8

DSO

132.1 143.4 130.5 134.4 36.9 34.4 31.9 29.8 41.5 41.6 39.1 38.1 45.6

DIO

166.3 140.0 129.0 144.1 144.7 125.9 127.4 106.2 95.9 109.1 105.8 97.8 118.2

DPO

18.0 18.0 15.6 20.7 23.0 22.7 22.7 21.2 14.8 20.8 17.4 22.5 21.8

Operating Cycle

298.4 283.5 259.5 278.6 181.6 160.3 159.4 136.0 137.4 150.7 144.9 135.9 163.8

Cash Conversion Cycle

280.5 265.5 243.9 257.9 158.6 137.6 136.7 114.9 122.5 129.9 127.5 113.5 142.0

All numbers in USD currency

Quarterly Financial Ratios Utah Medical Products

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

1.08 1.16 1.16 - 1.18 1.13 0.97 - 1.15 0.94 0.83 - 0.81 0.36 0.85 - 1 0.95 0.84 - 1.81 1.15 1.1 - 0.97 1.04 0.95 - 0.78 0.87 0.86 - 0.81 0.78 0.71 - 0.75 0.76 0.73 - 0.69 0.71 0.74 - 0.74 0.65 0.76 - 0.62 0.55 0.37

EBITDA per Share

- - 1.27 - 1.54 1.47 1.28 - 1.53 1.4 1.11 - 1.12 0.63 1.09 - 1.32 1.3 1.15 - 1.33 1.46 1.39 - 1.39 1.44 1.32 - 1.17 1.23 1.19 - 1.19 1.14 1.07 - 1.2 1.17 1.07 - 1.1 1.08 1.09 - 1.21 1.06 1.35 - 1.12 0.99 0.67

ROE %

14.16 14.93 15.30 11.01 14.87 14.74 14.11 13.75 13.22 12.25 10.33 10.50 11.50 12.31 14.52 14.57 14.07 18.00 19.36 20.85 13.81 10.85 10.96 10.89 18.36 17.96 17.71 13.59 17.97 18.10 17.59 12.39 16.77 16.76 16.96 12.98 17.22 17.09 17.05 13.10 18.44 19.54 19.90 15.52 21.01 21.16 21.31 13.63 5.49 4.86 3.28

ROA %

13.13 13.75 14.06 10.10 13.67 13.57 12.97 12.66 12.14 11.26 9.50 9.66 10.58 11.33 13.37 13.42 12.85 16.25 17.36 18.60 12.48 9.61 9.46 9.17 15.72 15.65 15.73 12.29 16.14 16.15 15.58 10.90 14.38 14.02 13.83 10.33 13.52 13.22 12.99 9.84 13.37 13.72 13.58 10.28 13.21 12.60 12.08 7.27 2.93 2.59 1.75

ROCE %

15.36 16.90 17.97 13.60 18.24 18.12 17.85 12.78 16.27 15.12 12.61 9.17 13.49 14.33 16.84 12.81 17.76 18.38 19.63 16.21 22.20 23.25 24.01 18.48 24.17 23.87 23.66 18.15 23.89 23.95 23.41 17.01 23.20 23.66 24.26 18.44 24.49 24.34 24.18 18.60 26.37 28.09 28.93 22.81 31.49 32.41 33.37 21.91 8.68 7.93 5.29

Current Ratio

17.4 15.0 13.1 12.9 11.6 13.4 11.3 13.6 12.2 12.4 12.0 12.5 12.5 12.5 12.5 12.6 12.6 12.6 12.6 9.3 9.3 9.3 9.3 6.3 6.3 6.3 6.3 11.0 10.4 10.4 10.4 8.3 8.3 8.3 8.3 4.9 4.9 4.9 4.9 4.0 4.0 4.0 4.0 3.0 3.0 3.0 3.0 2.1 2.1 2.1 2.1

DSO

25.9 26.3 34.1 - 38.6 36.2 40.2 35.3 34.3 31.7 34.4 31.2 35.7 42.6 37.0 36.6 34.6 36.5 37.0 37.0 34.7 32.9 31.8 32.4 32.6 30.5 30.4 - 30.4 27.9 34.4 - 41.9 40.0 41.3 - 40.0 40.9 42.0 - 39.4 39.5 38.2 - 37.8 39.5 37.0 - 40.1 41.6 -

DIO

175.8 178.5 182.9 - 149.7 127.1 133.0 - 125.9 114.5 138.5 - 142.6 148.0 147.4 - 123.3 145.2 159.3 - 120.6 124.0 122.6 - 131.9 - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

16.4 21.0 21.9 - 20.2 19.6 21.1 - 22.4 19.2 18.5 - 18.1 18.7 21.2 - 19.6 23.1 23.9 - 21.7 22.4 22.0 - 23.5 - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

201.7 204.8 217.0 - 188.3 163.3 173.2 35.3 160.2 146.2 172.9 31.2 178.3 190.6 184.4 36.6 158.0 181.7 196.3 37.0 155.3 157.0 154.4 32.4 164.5 30.5 30.4 - 30.4 27.9 34.4 - 41.9 40.0 41.3 - 40.0 40.9 42.0 - 39.4 39.5 38.2 - 37.8 39.5 37.0 - 40.1 41.6 -

Cash Conversion Cycle

185.3 183.8 195.1 - 168.2 143.7 152.1 35.3 137.8 127.0 154.4 31.2 160.3 171.8 163.3 36.6 138.4 158.6 172.4 37.0 133.6 134.6 132.4 32.4 141.0 30.5 30.4 - 30.4 27.9 34.4 - 41.9 40.0 41.3 - 40.0 40.9 42.0 - 39.4 39.5 38.2 - 37.8 39.5 37.0 - 40.1 41.6 -

All numbers in USD currency